| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.33 | 0.08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |